Lung cancer “breathalyzer” wins $100K Entrepreneurship Competition
Team’s smartphone-connected device can detect lung cancer early from a single breath.
Search Stories
Taking on melanoma, one cell at a time
In step toward personalized medicine, researchers are using single-cell analysis to unravel cancer’s secrets.
Why some tumors withstand treatment
Researchers uncover a mechanism that allows cancer cells to evade targeted therapies.
Paving the way for metastasis
Cancer cells remodel their environment to make it easier to reach nearby blood vessels.
McGovern Institute for Brain Research awards Scolnick Prize to neurogeneticist Cori Bargmann
Bargmann honored for her work on the genetic and neural mechanisms that control behavior in the nematode C. elegans.
Targeting cancer from many angles
Killian Award recipient Tyler Jacks fosters interdisciplinary, innovative cancer research.
Scientists discover how cancer cells escape blood vessels
Study offers new targets for drugs that may prevent cancer from spreading.
A new way to deliver microRNAs for cancer treatment
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.
Heidi Williams wins MacArthur “genius grant”
Economist who studies medical research and intellectual property wins $625,000 prize.
Capturing cell growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
New MIT report details benefits of investment in basic research
Authors highlight 15 research opportunities that could help boost the U.S. economy, benefit society.
How to identify drugs that work best for each patient
Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy.
Using sound waves to detect rare cancer cells
Acoustic device can rapidly isolate circulating tumor cells from patient blood samples.
New nanodevice defeats drug resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Proteins drive cancer cells to change states
When RNA-binding proteins are turned on, cancer cells get locked in a proliferative state.